How to Check a GLP-1 Pharmacy Before You Pay

Start with the legal name and address of the pharmacy that will actually dispense your medication. The telehealth website, payment processor, prescriber, and dispensing pharmacy may be different businesses. Verifying one does not verify all four.

FDA recommends checking an online pharmacy through the relevant state board of pharmacy and looking for a prescription requirement, a U.S. physical address and phone number, and access to a licensed pharmacist.¹ These are useful checks before payment, not a guarantee that every product or claim is appropriate.

1. Identify the dispensing business

Ask the provider for the pharmacy's legal name, physical location, phone number, and the product it expects to dispense. If it works with multiple pharmacies, ask how the pharmacy for your order will be identified and whether it can change on renewal.

Keep the written answer. When a package arrives, compare the dispensing label with that information. A provider's brand name or a logo in a checkout footer is not enough to match a pharmacy record.

FDA has warned about fraudulent compounded GLP-1 labeling, including products using the name of a real licensed pharmacy that did not make them.² If a label or communication seems inconsistent, contact the pharmacy using independently verified contact details rather than relying only on a number supplied by the seller.

2. Use the official state-board record

FDA's BeSafeRx page links to state pharmacy boards. Search the relevant board's public records for the actual legal entity and location, then examine license status and any available disciplinary information. When medication is shipped across state lines, confirm the authority relevant to dispensing into your state; ask the board if its records are unclear.¹

Match the address as well as the name. A chain or business group may have several locations with different records. A similarly named business is not necessarily the dispenser on your label.

Avoid treating a commercial directory badge, advertising certification, or customer-review score as a substitute for the licensing authority's record. Those sources can answer other questions, but they do not grant a pharmacy license.

3. Understand what “503B registered” means

If the service identifies a 503B outsourcing facility, look for that exact facility in FDA's registered-outsourcing-facility table. The table includes registration, inspection, and related information, with links where available.³

Registration is not FDA approval of every finished product, and a facility's appearance on the list does not mean FDA has inspected it. Check the location and dates rather than interpreting “FDA registered” as “FDA approved.” A 503A pharmacy is a different statutory category; absence from the 503B table does not by itself establish that a state-licensed 503A pharmacy is unlawful.

The distinction is explained in our compounded-versus-brand guide. Neither category makes a compounded product an approved generic equivalent.

4. Read inspections and recalls in context

FDA publishes compounding inspections, recalls, warning letters, and other actions. Search the facility's name and address, and read the scope and date of the actual document.⁴ A recall can concern a particular product, lot, and period rather than everything ever dispensed by that business.

An inspection Form 483 records investigators' observations; it is not a final agency determination. Conversely, an old registration entry or a reassuring response letter does not erase a current unresolved issue. Look for subsequent documents and use the regulator's current record where available.

FDA's federal table does not replace state disciplinary records. These checks work together, and a clean-looking search is not proof that a facility or product has no risk.

5. Verify the product as well as the pharmacy

Ask whether you are receiving an approved brand or a compounded preparation, the exact active ingredient and formulation, and why that option is appropriate. FDA has raised concerns about semaglutide sodium and acetate salts, dosing errors, and unapproved products marketed with misleading claims.²

A licensed pharmacy cannot make every formulation clinically equivalent simply by dispensing it. The oral-tirzepatide and gummy guide explains why evidence for an injection cannot automatically support a different route. For injectable compounds, the dosing-error guide explains why a syringe-unit number without the correct concentration is inadequate.

Also ask the prescriber about the lawful patient-specific basis for compounding. Current FDA restrictions matter after national shortage allowances ended; a generic promise of “personalization” does not settle that question.⁵

6. Check support and financial terms

Confirm whom to contact for a damaged shipment, an unclear label, a suspected quality issue, or an adverse reaction. Keep the packaging and order details needed to identify the product. Do not continue using a questionable product while trying to resolve a label discrepancy through a sales chat.

Our provider-selection checklist adds clinician access and cancellation questions. Use the billing-cycle calculator to compare recurring charges only after you understand the medicine and care being purchased. A lower price cannot compensate for an unidentified dispenser or an unanswered product question.